Cargando…
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Today, cancer treatment is one of the fundamental problems facing clinicians and researchers worldwide. Efforts to find an excellent way to treat this illness continue, and new therapeutic strategies are developed quickly. Adoptive cell therapy (ACT) is a practical approach that has been emerged to...
Autores principales: | Hadiloo, Kaveh, Tahmasebi, Safa, Esmaeilzadeh, Abdolreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165596/ https://www.ncbi.nlm.nih.gov/pubmed/37158883 http://dx.doi.org/10.1186/s12935-023-02923-9 |
Ejemplares similares
-
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
por: Hadiloo, Kaveh, et al.
Publicado: (2023) -
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
por: Elahi, Reza, et al.
Publicado: (2021) -
iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022) -
Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells
por: Elahi, Reza, et al.
Publicado: (2018) -
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
por: Faeq, Mohammed Hikmat, et al.
Publicado: (2023)